The possible mechanism is that in the environment of hyperlipidaemia and hyperglycaemia, pro-inflammatory macrophages (M1-type) delay wound healing in diabetic patients, while anti-inflammatory macrophages (M2-type) have weakened functions that reduce VEGF production and the adhesion to endothelial cells. The gene discussed is VEGFA; the disease is hyperlipidemia.